VBIO ▼ -0.5% - Valion Bio, Inc.
$VBIO - Valion Bio (Nasdaq:VBIO): Oral Mucosal Entolimod Could Offer a New Needle-Free Deployment Path to Support Growing Need for Scalable Civilian Radiation Preparedness Should Nuclear Infrastructure Expand to Support Data Centers
09-OCT-2026 07:47 AM ET
Share this post
More filings for $VBIO
VBIO ▼ -1.3% - Valion Bio, Inc.Oct 28, 2026VBIO ▲ +18.9% - Valion Bio, Inc.Oct 26, 2026VBIO ▲ +4.1% - Valion Bio, Inc.Oct 21, 2026VBIO ▼ -9.7% - Valion Bio, Inc.Oct 15, 2026VBIO ▲ +39.3% - Valion Bio, Inc.Oct 15, 2026VBIO ▼ -0.6% - Valion Bio, Inc.Oct 14, 2026
View full $VBIO filing history →💬 Comments
Loading comments…
Leave a comment
